just to provide some reference for speed of TNBC approval
Keytruda, an approved Merck drug, received BTD approval 4/19/19 for advanced renal cell carcinoma, but still hasn't been received FDA approval for this indication. I'm not saying that Leronlimab won't be approved in 2020, but I think this example (and there are others) should be used as reference. After receiving BTD approval, an FDA approval within 9 months would appear to be record breaking.
Leronlimab may have that potential, but expecting that to happen just isn't reasonable. Yes, its saving lives and the MOA appears to be the real deal in cancer BUT the FDA doesn't work at that speed, as they have shown us in the past. While there were hiccups getting the TNBC trail started last year, I thought it was laughable how people thought it would be approved in 2019, delays or not. This is a great board with a lot of different perspective (WARNING! unpopular opinions to follow), but a lot of people here are blinded by the potential of this drug and the idea of becoming millionaires off a penny stock. I am hoping for this as well, but don't expected it happen as fast as some here. I am long CYDY, believe in the science 99.99%, but also understand how the real world works. I stay mindful to the idea that leronlimab may "set records" for approval in cancer, but don't expect it, or project that view on a daily/weekly basis. I would love for Leronlimab to be approved this Tuesday, but also want to keep my expectations grounded. While this board is very informative and managed much better than Ihub, there may be a little too much positivity, and I wish the skeptics/devils advocates wouldn't all be bullied off.
Keytruda, an approved Merck drug, received BTD approval 4/19/19 for advanced renal cell carcinoma, but still hasn't been received FDA approval for this indication. I'm not saying that Leronlimab won't be approved in 2020, but I think this example (and there are others) should be used as reference. After receiving BTD approval, an FDA approval within 9 months would appear to be record breaking.
Leronlimab may have that potential, but expecting that to happen just isn't reasonable. Yes, its saving lives and the MOA appears to be the real deal in cancer BUT the FDA doesn't work at that speed, as they have shown us in the past. While there were hiccups getting the TNBC trail started last year, I thought it was laughable how people thought it would be approved in 2019, delays or not. This is a great board with a lot of different perspective (WARNING! unpopular opinions to follow), but a lot of people here are blinded by the potential of this drug and the idea of becoming millionaires off a penny stock. I am hoping for this as well, but don't expected it happen as fast as some here. I am long CYDY, believe in the science 99.99%, but also understand how the real world works. I stay mindful to the idea that leronlimab may "set records" for approval in cancer, but don't expect it, or project that view on a daily/weekly basis. I would love for Leronlimab to be approved this Tuesday, but also want to keep my expectations grounded. While this board is very informative and managed much better than Ihub, there may be a little too much positivity, and I wish the skeptics/devils advocates wouldn't all be bullied off.
7
